Start-Up Previews, March 2013
Executive Summary
This Month's Profile Group: Nanomedicine: Will It Get Big?, features profiles of Blend Therapeutics, Kala Pharmaceuticals, Qualiber, and Uroboros Technologies. Plus these Start-Ups Across Health Care: Ceterix Orthopaedics, Flux Medical, Neuros Medical, and Tunitas Therapeutics.
You may also be interested in...
Neuros Medical Inc.
Neuros Medical Inc.’s Altius is an implantable device that transmits a high-frequency electrical signal to a targeted nerve in the stump of a patient experiencing chronic pain stemming from a major limb amputation. Blocking the nerve activity eliminates the pain.
Ceterix Orthopaedics Inc.
The meniscal suture passer from Ceterix Orthopaedics Inc. is a handheld surgical instrument that due to its small size and design facilitates meniscus repair. Because it leaves the cushion of the meniscus intact, the company believes its device will help patients avoid the arthritic changes that frequently accompany meniscus removal.
Flux Medical NV
Traditional ablation for treating atrial fibrillation involves disconnecting the electrical pathway that causes the abnormal rhythm, and the procedure can take anywhere from two to four hours, thus limiting the number of cases a cath lab can handle each day. The self-expanding pulmonary vein implant in development at Flux Medical NV is easy to insert inside the vein and should make the procedure much shorter, allowing a cath lab to schedule up to six to eight cases a day.